Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
China
· Delayed Price · Currency is CNY 16.77
+0.14 (0.84%)
Mar 10, 2026, 11:05 AM CST
SHA:603456 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 14,663 | 12,247 | 21,777 | 35,397 | 46,842 | 28,827 | Upgrade
|
| Market Cap Growth | 18.00% | -43.76% | -38.48% | -24.43% | 62.49% | 156.68% | Upgrade
|
| Enterprise Value | 12,157 | 10,155 | 18,935 | 34,444 | 46,532 | 29,243 | Upgrade
|
| Last Close Price | 16.63 | 13.26 | 22.60 | 39.01 | 51.48 | 32.61 | Upgrade
|
| PE Ratio | 20.31 | 20.21 | 21.08 | 38.43 | 73.90 | 75.75 | Upgrade
|
| Forward PE | 13.41 | 10.72 | 15.86 | 32.74 | 63.29 | 63.36 | Upgrade
|
| PS Ratio | 2.74 | 2.37 | 3.94 | 6.50 | 11.53 | 10.89 | Upgrade
|
| PB Ratio | 1.66 | 1.42 | 2.55 | 6.59 | 10.23 | 9.34 | Upgrade
|
| P/TBV Ratio | 1.80 | 1.54 | 2.78 | 7.48 | 11.44 | 10.40 | Upgrade
|
| P/FCF Ratio | 13.33 | 119.26 | 50.54 | 69.14 | 479.75 | 340.48 | Upgrade
|
| P/OCF Ratio | 8.73 | 12.35 | 16.01 | 28.88 | 69.14 | 72.00 | Upgrade
|
| EV/Sales Ratio | 2.27 | 1.97 | 3.43 | 6.33 | 11.45 | 11.05 | Upgrade
|
| EV/EBITDA Ratio | 8.81 | 9.15 | 12.80 | 25.17 | 45.74 | 40.68 | Upgrade
|
| EV/EBIT Ratio | 12.60 | 14.20 | 17.17 | 33.58 | 64.10 | 62.67 | Upgrade
|
| EV/FCF Ratio | 11.05 | 98.89 | 43.95 | 67.28 | 476.58 | 345.39 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.05 | 0.05 | 0.07 | 0.15 | 0.30 | Upgrade
|
| Debt / EBITDA Ratio | 0.10 | 0.37 | 0.28 | 0.26 | 0.69 | 1.31 | Upgrade
|
| Debt / FCF Ratio | 0.12 | 4.01 | 0.96 | 0.69 | 7.22 | 11.08 | Upgrade
|
| Net Debt / Equity Ratio | -0.29 | -0.27 | -0.33 | -0.14 | -0.10 | 0.19 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.88 | -2.11 | -1.89 | -0.54 | -0.43 | 0.82 | Upgrade
|
| Net Debt / FCF Ratio | -2.34 | -22.76 | -6.48 | -1.45 | -4.53 | 6.92 | Upgrade
|
| Asset Turnover | 0.49 | 0.47 | 0.59 | 0.73 | 0.68 | 0.55 | Upgrade
|
| Inventory Turnover | 2.02 | 1.84 | 1.77 | 1.96 | 1.93 | 1.69 | Upgrade
|
| Quick Ratio | 2.33 | 1.96 | 2.54 | 0.84 | 0.96 | 0.64 | Upgrade
|
| Current Ratio | 3.39 | 2.97 | 3.81 | 1.80 | 1.81 | 1.41 | Upgrade
|
| Return on Equity (ROE) | 8.29% | 7.08% | 14.84% | 18.51% | 16.55% | 12.78% | Upgrade
|
| Return on Assets (ROA) | 5.55% | 4.07% | 7.34% | 8.58% | 7.54% | 6.03% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.35% | 9.89% | 18.58% | 19.54% | 15.84% | 11.52% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.60% | 7.90% | 12.00% | 18.00% | 14.60% | 13.90% | Upgrade
|
| Earnings Yield | 4.93% | 4.95% | 4.75% | 2.60% | 1.35% | 1.32% | Upgrade
|
| FCF Yield | 7.50% | 0.84% | 1.98% | 1.45% | 0.21% | 0.29% | Upgrade
|
| Dividend Yield | 2.38% | 2.26% | 2.21% | 1.03% | 0.49% | 0.61% | Upgrade
|
| Payout Ratio | 64.31% | 77.76% | 37.37% | 25.50% | 30.07% | 53.30% | Upgrade
|
| Buyback Yield / Dilution | 2.06% | -0.07% | -7.33% | 0.50% | -3.00% | -2.16% | Upgrade
|
| Total Shareholder Return | 4.44% | 2.20% | -5.12% | 1.53% | -2.52% | -1.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.